FDA Commish ‘Committed’ To Progressing On CBD, Other Cannabinoids
By
Posted on
He acknowledged that hemp extracts and derivatives are already in widespread use
The head of the U.S. Food and Drug Administration says he is “very committed” to making progress on CBD, but his agency needs more authority to do so.
The comments by FDA Commissioner Robert Califf came Thursday during a U.S. House of Representatives budget hearing.
Asked about “hemp products,” Califf noted there are an “amazing plethora of derivatives of the cannabis plant,” calling it “quite profound and astounding,” Cannabis Wire reported.
To Read The Rest Of This Article On Hemp Industry Daily, Click Here
